For example, liraglutide (LRG) and Fibronectin type III domain-containing 5 (FNDC5) protein can improve hepatic steatosis and reduces hepatic lipid accumulation by inducing autophagy [201,202]. The gene discussed is FNDC5; the disease is Hepatic steatosis.